CLINICAL_TRIALS
research
· 2025-01-03
Clinical Trial Update: Effects of Intranasal Oxytocin in the Treatment of Benzodiazepine Withdrawal: A Pilot RCT [Phase 2]
Summary
This is a Phase 2 pilot randomized trial evaluating intranasal oxytocin for benzodiazepine withdrawal in people with benzodiazepine dependence. Recruitment is o…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: St. Olavs Hospital | Conditions: Benzodiazepine Dependence | Phase 2 | Status: RECRUITING